Abstract:Mucormycosis, a severe fungal infection caused by fungi, particularly , has prompted the development of new and more potent antifungal drugs due to the emergence of drug-resistant strains. Currently used drugs are known to be toxic to human cells also, which is a major drawback in their administration. Antifungal drugs commercially under use and their structurally modified analogues along with 30 plants reported with antifungal activity from IMPPAT database, totalling 229 compounds, were screened against the best modelled structure of Chitin Synthase, a key target enzyme of by molecular docking studies. Computerized methods to assess absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles was employed to further filter key lead drug candidates from among the docked ligands that could act as potential antifungal medications. Modified structures of Posaconazole, Nikkomycin and Isavuconazole were found to give better docking results than compared to the original drugs, though they failed to comply with ADMET parameters. Among the phytochemicals, 1-nonacosanol displayed binding affinity (highest LibDock score) greater than the synthetic drugs and their derivatives, though it too failed to comply with ADMET parameters. The phytochemical Dihydrocapsaicin was found to be the best compound that satisfied all the parameters such as ADMET, TOPKAT, Lipinski’s and Veber’s rule along with good binding affinity. All in all, this novel study paves a way to investigate the interaction of Chitin Synthase inhibitors at molecular level to achieve an alternative solution with less toxic effects to treat Mucormycosis.

What problem does this paper attempt to address?

The paper attempts to address the problem of finding new, more effective antifungal drugs to treat mucormycosis caused by Rhizopus delemar. Specifically, the researchers used computer-aided methods to screen existing antifungal drugs and their structural modifications, as well as natural products with antifungal activity from the Indian Medicinal Plants, Phytochemistry And Therapeutics (IMPPAT) database, to discover potential drug candidates that can effectively inhibit chitin synthase in Rhizopus delemar. ### Background Issues: 1. **High Toxicity**: Currently used antifungal drugs such as Amphotericin B and Isavuconazole, although effective, also have significant toxicity to human cells. 2. **Drug Resistance**: Some fungal strains have developed resistance to existing drugs. 3. **High Treatment Costs**: Surgical treatment and long-term medication make the treatment expensive. 4. **High Mortality Rate**: The mortality rate of mucormycosis is very high, especially in patients with compromised immune systems. ### Research Objectives: 1. **Discover New Drug Candidates**: Screen compounds that can effectively bind and inhibit chitin synthase through computer-aided molecular docking studies. 2. **Evaluate Drug Properties**: Use computational methods to assess the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these compounds to ensure their safety and efficacy in vivo. 3. **Validate Potential Drugs**: Further validate compounds with the best binding affinity and meeting ADMET standards as potential new antifungal drugs. ### Main Methods: 1. **Protein Modeling**: Construct a 3D structural model of Rhizopus delemar chitin synthase. 2. **Molecular Docking**: Perform molecular docking of existing antifungal drugs and their structural modifications, as well as 174 natural products with antifungal activity from the IMPPAT database, with chitin synthase. 3. **ADMET Analysis**: Evaluate the ADMET properties of all screened compounds to ensure their safety and efficacy in vivo. ### Results: 1. **Structurally Modified Drugs**: Structurally modified Posaconazole, Nikkomycin, and Isavuconazole showed better binding affinity than the original drugs but failed to meet ADMET parameters. 2. **Natural Products**: 1-Nonacosanol showed higher binding affinity than synthetic drugs but also failed to meet ADMET parameters. 3. **Best Candidate**: Dihydrocapsaicin not only had good binding affinity but also met all ADMET parameters, including TOPKAT, Lipinski's rule, and Veber's rule. ### Conclusion: The study successfully screened some potential new antifungal drug candidates through computer-aided methods, particularly dihydrocapsaicin, providing a new direction for developing safer and more effective treatments for mucormycosis.

Chitin synthase targeting antifungal agents for Mucormycosis (Black fungus disease) caused by - An study

Design and synthesis of spiro[pyrrolidine-3,3'-quinoline]-2,2'-dione derivatives as novel antifungal agents targeting chitin synthase

Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1 H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase

Molecular Architecture of Chitin and Chitosan-Dominated Cell Walls in Zygomycetous Fungal Pathogens by Solid-State NMR

Design, synthesis and biological evaluation of novel spiro-quinazolinone derivatives as chitin synthase inhibitors and antifungal agents

Projecting phytochemical bacoside A anti-mucorale agent: An in-silico and in-vitro assessment

In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach

Design, Synthesis and Evaluation of Novel Quinazoline-2,4-dione Derivatives As Chitin Synthase Inhibitors and Antifungal Agents

Spiro[benzoxazine-piperidin]-one derivatives as chitin synthase inhibitors and antifungal agents: Design, synthesis and biological evaluation

Computational targeting of iron uptake proteins in Covid-19 induced mucormycosis to identify inhibitors via molecular dynamics, molecular mechanics and density function theory studies

Synthesis and Biological Evaluation of Novel Phosphoramidate Derivatives of Coumarin As Chitin Synthase Inhibitors and Antifungal Agents

Design, Synthesis and Biological Evaluation of Novel Diazaspiro[4.5]decan-1-one Derivatives As Potential Chitin Synthase Inhibitors and Antifungal Agents.

Potent Chitin Synthase Inhibitors from Plants

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Synthesis and biological evaluation of novel 3-substituted amino-4-hydroxylcoumarin derivatives as chitin synthase inhibitors and antifungal agents

Design, Synthesis and Biological Evaluation of Novel Diazaspirodecanone Derivatives Containing Piperidine-4-carboxamide As Chitin Synthase Inhibitors and Antifungal Agents.

Natural Isatin Derivatives Against Black Fungus: In Silico Studies

The Computational Interaction Analyses of Some Vitamin D-Related Compounds with Sterol 14-Demethylase (CYP51) – Could It Be a Glimmer of Hope to Find New Anti-Mucormycotic Drugs Extracted from Plants-Derived Sterols?

Selection and Structural Analysis by Bioinformatic Tools of Several Proteins Involved in Chitin Biosynthesis in the Fungus Mucor lusitanicus

Design, Synthesis and Evaluation of Antifungal Activity of Pyrazoleacetamide Derivatives